; and (ii) the type of antimicrobial drugs, if any, that the individual received for the infection from the discharging or transferring provider and the stop date for those drugs; (B) methods for transmitting information; (C) timeframes for transmitting information; and (D) any other information determined appropriate. (3) Working group participants The working group under paragraph (1) shall be composed of representatives from— (A) patient groups; (B) hospitals; (C) long-term care facilities; (D) accreditation agencies; (E) State and local health departments